Page last updated: 2024-10-22

acetazolamide and Chest Pain

acetazolamide has been researched along with Chest Pain in 1 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Chest Pain: Pressure, burning, or numbness in the chest.

Research Excerpts

ExcerptRelevanceReference
"A 61-year-old man with uncontrolled increased intraocular pressure after cataract surgery was treated with acetazolamide."8.31A Case of Acute Chest Pain After Acetazolamide to Treat Uncontrolled Increased Intraocular Pressure. ( Al-Khersan, H; Anibire, O; Williams, BK, 2023)
"A 61-year-old man with uncontrolled increased intraocular pressure after cataract surgery was treated with acetazolamide."4.31A Case of Acute Chest Pain After Acetazolamide to Treat Uncontrolled Increased Intraocular Pressure. ( Al-Khersan, H; Anibire, O; Williams, BK, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Anibire, O1
Al-Khersan, H1
Williams, BK1

Other Studies

1 other study available for acetazolamide and Chest Pain

ArticleYear
A Case of Acute Chest Pain After Acetazolamide to Treat Uncontrolled Increased Intraocular Pressure.
    JAMA ophthalmology, 2023, 04-01, Volume: 141, Issue:4

    Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Cataract Extraction; Chest Pain; Glaucoma; Humans; Int

2023